{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:04:46Z","timestamp":1783922686513,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Biomaterials"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.celbio.2026.100535","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:05:01Z","timestamp":1783695901000},"page":"100535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic deletion of P-glycoprotein from gliomas via the focused ultrasound delivery of a duplex CRISPR-Cas9 ribonucleoprotein system"],"prefix":"10.1016","author":[{"given":"Anna C.","family":"Debski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Gorick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Breza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-2102","authenticated-orcid":false,"given":"Richard J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celbio.2026.100535_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celbio.2026.100535_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celbio.2026.100535_bib3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.celbio.2026.100535_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.celbio.2026.100535_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hemonc.2021.05.006","article-title":"The phenomenon of multidrug resistance in glioblastomas","volume":"15","author":"Chernov","year":"2022","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"10.1016\/j.celbio.2026.100535_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41694-9","article-title":"Breaking barriers for glioblastoma with a path to enhanced drug delivery","volume":"14","author":"Noorani","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100535_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080771","article-title":"The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.celbio.2026.100535_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: Myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100535_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11060-020-03408-9","article-title":"Convection-enhanced drug delivery for glioblastoma: a review","volume":"151","author":"D\u2019Amico","year":"2021","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.celbio.2026.100535_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/cns.15.12","article-title":"Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics","volume":"4","author":"Ung","year":"2015","journal-title":"CNS Oncol."},{"key":"10.1016\/j.celbio.2026.100535_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114583","article-title":"Applications of focused ultrasound-mediated blood-brain barrier opening","volume":"191","author":"Gorick","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.celbio.2026.100535_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood\u2013brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.celbio.2026.100535_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00352","article-title":"Current clinical investigations of focused ultrasound blood-brain barrier disruption: A review","volume":"21","author":"Durham","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.celbio.2026.100535_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0271678X211046129","article-title":"A review of bioeffects induced by focused ultrasound combined with microbubbles on the neurovascular unit","volume":"42","author":"Chen","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.celbio.2026.100535_bib15","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment","volume":"61","author":"Waghray","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.celbio.2026.100535_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: what do we currently know?","volume":"8","author":"Pilotto Heming","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.celbio.2026.100535_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00265","article-title":"Perplexing Role of P-Glycoprotein in Tumor Microenvironment","volume":"10","author":"Robinson","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celbio.2026.100535_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1078-0432.CCR-19-2182","article-title":"Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celbio.2026.100535_bib19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3390\/curroncol30020152","article-title":"Application of CRISPR\/Cas9 Technology in Cancer Treatment: A Future Direction","volume":"30","author":"Rabaan","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.celbio.2026.100535_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01518-8","article-title":"Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celbio.2026.100535_bib21","doi-asserted-by":"crossref","first-page":"ii24","DOI":"10.1093\/neuonc\/nou355","article-title":"Sui generis: gene therapy and delivery systems for the treatment of glioblastoma","volume":"17","author":"Kane","year":"2015","journal-title":"Neuro. Oncol"},{"key":"10.1016\/j.celbio.2026.100535_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.621831","article-title":"Current Approaches for Glioma Gene Therapy and Virotherapy","volume":"14","author":"Banerjee","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.celbio.2026.100535_bib23","first-page":"181","article-title":"CRISPR\/Cas9, a new approach to successful knockdown of ABCB1\/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line","volume":"21","author":"Norouzi-Barough","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.celbio.2026.100535_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/thno.47007","article-title":"Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.celbio.2026.100535_bib25","article-title":"CRISPR\/Cas9 Targeting Liposomes Knocked down Multidrug Resistance Proteins in Brain Endothelial Cells as a Model to Predict Potential Pharmacoresistance","volume":"222","author":"Yang","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.celbio.2026.100535_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.23","article-title":"Production and clinical development of nanoparticles for gene delivery","volume":"3","author":"Chen","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.celbio.2026.100535_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.celbio.2026.100535_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1574884713666180412150153","article-title":"Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges","volume":"13","author":"Khaitan","year":"2018","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.celbio.2026.100535_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celbio.2026.100535_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100535_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100535_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310395","article-title":"Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma","volume":"62","author":"\u00c1lvarez-Benedicto","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.celbio.2026.100535_bib33","doi-asserted-by":"crossref","first-page":"21321","DOI":"10.1021\/jacs.1c09822","article-title":"Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.celbio.2026.100535_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1006\/bbrc.2001.4312","article-title":"Isolation of Endothelial Cells from Brain, Lung, and Kidney: Expression of the Multidrug Resistance P-Glycoprotein Isoforms","volume":"281","author":"Demeule","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celbio.2026.100535_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BJ20060012","article-title":"Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket","volume":"396","author":"Loo","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.celbio.2026.100535_bib36","article-title":"Equilibrated Atomic Models of Outward-Facing P-glycoprotein and Effect of ATP Binding on Structural Dynamics","volume":"5","author":"Pan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celbio.2026.100535_bib37","doi-asserted-by":"crossref","first-page":"13386","DOI":"10.1073\/pnas.1309275110","article-title":"Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain","volume":"110","author":"Ward","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100535_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2022.03.148","article-title":"Knockout of P-glycoprotein abolish the collateral sensitivity of CHORC5 multidrug resistant cells","volume":"608","author":"Limniatis","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celbio.2026.100535_bib39","article-title":"Mouse models of glioblastoma for the evaluation of novel therapeutic strategies","volume":"3","author":"Haddad","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.celbio.2026.100535_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411722","article-title":"Paclitaxel Delivery to the Brain for Glioblastoma Treatment","volume":"24","author":"Abdel-Haq","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celbio.2026.100535_bib41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/anie.201610209","article-title":"Non-viral CRISPR\/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA","volume":"56","author":"Miller","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.celbio.2026.100535_bib42","article-title":"Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.celbio.2026.100535_bib43","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jcbfm.2014.71","article-title":"The size of blood\u2013brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure","volume":"34","author":"Chen","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.celbio.2026.100535_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2015.08.059","article-title":"Drug and gene delivery across the blood\u2013brain barrier with focused ultrasound","volume":"219","author":"Timbie","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100535_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10198","article-title":"Transcriptomic response of brain tissue to focused ultrasound-mediated blood-brain barrier disruption depends strongly on anesthesia","volume":"6","author":"Mathew","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.celbio.2026.100535_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.celbio.2026.100535_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100535_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay1344","article-title":"Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection","volume":"6","author":"Curley","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celbio.2026.100535_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01348","article-title":"Recent advances in the use of focused ultrasound for magnetic resonance image-guided therapeutic nanoparticle delivery to the central nervous system","volume":"10","author":"Fisher","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.celbio.2026.100535_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108518","article-title":"Anticancer drug delivery by focused ultrasound-mediated blood-brain\/tumor barrier disruption for glioma therapy: From benchside to bedside","volume":"250","author":"B\u00e9rard","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celbio.2026.100535_bib51","article-title":"Improved anti-glioblastoma efficacy by IL-13R\u03b12 mediated copolymer nanoparticles loaded with paclitaxel","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celbio.2026.100535_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15053-x","article-title":"Multiplexed CRISPR technologies for gene editing and transcriptional regulation","volume":"11","author":"McCarty","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100535_bib53","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s12276-025-01500-6","article-title":"Applications of multiplexed CRISPR\u2013Cas for genome engineering","volume":"57","author":"Cheng","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celbio.2026.100535_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2018.01.001","article-title":"The Multiplexed CRISPR targeting platforms","volume":"28","author":"Cao","year":"2018","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.celbio.2026.100535_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166061","article-title":"Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles","volume":"12","author":"Aryal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.celbio.2026.100535_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celbio.2026.100535_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-6152-7","article-title":"Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 AND GST-\u03c0 in human glioma","volume":"74","author":"Calatozzolo","year":"2005","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.celbio.2026.100535_bib58","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.18632\/oncotarget.28018","article-title":"Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas","volume":"12","author":"Gould","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.celbio.2026.100535_bib59","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celbio.2026.100535_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030513","article-title":"Clinical Trials of Focused Ultrasound for Brain Tumors","volume":"17","author":"Lu","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.celbio.2026.100535_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00558","article-title":"Enhanced Anti-glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Cell Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562326001911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562326001911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:07:33Z","timestamp":1783919253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050562326001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"alternative-id":["S3050562326001911"],"URL":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100535","relation":{},"ISSN":["3050-5623"],"issn-type":[{"value":"3050-5623","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic deletion of P-glycoprotein from gliomas via the focused ultrasound delivery of a duplex CRISPR-Cas9 ribonucleoprotein system","name":"articletitle","label":"Article Title"},{"value":"Cell Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100535"}}